Medicared For All Logo

Olanrewaju Esan MD in W Hempstead, New York

Home New York W Hempstead

Olanrewaju Esan MD has Critical Care (intensivists) as his primary medical specialty. Their primary office is: 320 Wilson St in W Hempstead, New York. They attended Sorry, his university is not listed and graduated in 1992 (around 32 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Olanrewaju O Esan MD Office Phone and Directions

Olanrewaju Esan MD
320 Wilson St
W Hempstead, New York 11552
516-485-5864


Patient Ratings
Please rate your experience with Olanrewaju Esan MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 516-485-5864


Enter a starting address:


Healthcare Info for Olanrewaju Esan MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, PULMONARY DISEASE, SLEEP MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1992
The Primary Medical Specialty for Olanrewaju Esan MD is listed as: Critical Care (intensivists)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 32
PAC (PECOS ID)#: 2567472269
NPI #: 1861494239
NPI Created On: 08/15/2005
NPI Last Updated Listed as: 05/25/2017
Primary Taxonomy Code: 207RC0200X
License Number:
211598
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Yoruba.


Services and Procedures include:

  1. Measurement and graphic recording of total and timed exhaled air capacity
  2. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  3. Determination of lung volumes using plethysmography
  4. Measurement of lung diffusing capacity
  5. Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
  6. New patient office or other outpatient visit, typically 60 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Established patient office or other outpatient, visit typically 40 minutes
  9. Initial hospital inpatient care, typically 70 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Critical care delivery critically ill or injured patient, first 30-74 minutes
  13. Critical care delivery critically ill or injured patient
  14. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801660898

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801665581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801958021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802066635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802168075

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802218535

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802374515

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802397281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802590295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802776811

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry